Annapolis Financial Services, LLC Viatris Inc Transaction History

Annapolis Financial Services, LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 17, 2024	SELL	$11.27 - $13.53 $3,245 - $3,896	-288 Reduced 99.31%	2 $0
Q3 2023 Oct 30, 2023	BUY	$9.59 - $11.35 $258 - $306	27 Added 10.27%	290 $2,000
Q1 2023 Apr 17, 2023	SELL	$9.2 - $12.26 $303 - $404	-33 Reduced 11.15%	263 $2,000
Q4 2022 Jan 20, 2023	SELL	$8.72 - $11.56 $270 - $358	-31 Reduced 9.48%	296 $0
Q3 2022 Oct 21, 2022	BUY	$8.48 - $11.13 $262 - $345	31 Added 10.47%	327 $3,000
Q2 2022 Jul 22, 2022	BUY	$9.95 - $12.27 $149 - $184	15 Added 5.34%	296 $3,000
Q1 2022 Apr 29, 2022	SELL	$9.81 - $15.4 $676 - $1,062	-69 Reduced 19.71%	281 $3,000
Q4 2021 Feb 11, 2022	BUY	$12.09 - $14.68 $72 - $88	6 Added 1.74%	350 $5,000
Q3 2021 Nov 09, 2021	BUY	$13.25 - $15.13 $318 - $363	24 Added 7.5%	344 $5,000
Q2 2021 Aug 04, 2021	SELL	$12.97 - $16.15 $12 - $16	-1 Reduced 0.31%	320 $5,000
Q1 2021 May 06, 2021	BUY	$13.59 - $18.54 $3,383 - $4,616	249 Added 345.83%	321 $4,000
Q4 2020 Feb 11, 2021	BUY	$14.3 - $18.74 $1,029 - $1,349	72 New	72 $1,000

1,141

988M

2.34M

2.21M

Ticker VTRS
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,212,669,952
Market Cap $11.5B
Description
Viatris Inc. operates as a healthcare company worldwide. The company operates in four segments: Developed Markets, Greater China, JANZ, and Emerging Markets. It offers prescription brand drugs, generic drugs, complex generic drugs, biosimilars, and active pharmaceutical ingredients (APIs). The company offers drugs in various therapeutic areas, i...

Get notified when there are updates to the investment portfolio of Annapolis Financial Services, LLC, based on Form 13F filings with the SEC.

Stay updated on Annapolis Financial Services, LLC with notifications on news.